The researchers found that low micromolar concentrations of the chemical were able to reduce the replication of six strains of SARS-CoV-2 by 50 percent.
What’s more, their findings were also positive when it came to the Omicron variant.
The team found that using sulforaphane resulted in a “significant” decrease in both the viral load, or amount of virus:
- In the lungs (17 percent decrease)
- Upper respiratory tract (nine percent decrease)
- The amount of lung injury (29 percent decrease).
Plus, the chemical also saw a drop in inflammation in the lungs, while protecting the cells from a hyperactive immune response which seems to be one of the key factors that has caused many to die from coronavirus.